Qi Gong for Health & Longevity - Quick Reference Sheet

Qi Gong for Health & Longevity

Created on 09/14/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Slow Chinese movement routines pairing gentle postures with controlled breathing and focused attention. Controlled studies show lower resting blood pressure, better sleep, less low mood and fatigue, steadier balance, and better blood sugar control. Harms are minor, mostly temporary muscle and joint soreness. The firmest ground is blood pressure, sleep and steadiness; several effects shrink against other gentle movement. (Full Review)

Protocol

Standard protocol
Baduanjin, 30–45 min
Five to seven sessions weekly, for a minimum of 12 weeks before assessing response. The regimen underlying most positive trials.
Minimum effective dose
30–49 min, 5–7× weekly
Identified as optimal in a dose-response analysis. Blood pressure trials averaged 28 minutes per session over 17 weeks.
Best time of day
Morning
Traditional and matching most trial protocols. Evening sessions suit sleep-quality goals; vigorous late-evening standing work is argued against.
Time to effect
Blood pressure & blood sugar
12–24 weeks
Measured at 12 to 24 weeks in most trials. Starting pressure above 140/90 mmHg predicts the largest measurable response.
Sleep & mood
4–6 weeks
The earliest changes to appear. Evening sessions of 20–30 minutes finishing at least an hour before bed suit the sleep goal.
Balance
12 weeks minimum
No acute sensation marks progress, so practitioners frequently quit before the 12-week point at which measurable change begins.

Benefits

Contraindications
  • Acute coronary syndrome or myocardial infarction within 90 days, or unstable angina, until cleared for light exercise
  • Uncontrolled resting hypertension at or above 180/110 mmHg, until pharmacologically controlled
  • Acute vertebral compression fracture, or severe osteoporosis with a spine T-score below −3.5
  • Acute psychosis, first-episode schizophrenia, or an active dissociative disorder
  • Symptomatic orthostatic hypotension with a systolic drop greater than 20 mmHg on standing (standing forms; seated forms remain appropriate)
  • Acute retinal detachment or eye surgery within six weeks
Key Interactions
  • Antihypertensive medications: caution (lisinopril, amlodipine, hydrochlorothiazide)
  • Insulin and sulfonylureas: caution (glipizide, glyburide; sessions beyond 45 minutes)
  • Beta-blockers: monitor (metoprolol, atenolol)
  • Sedatives and benzodiazepines: monitor (diazepam, lorazepam, zolpidem)
  • Over-the-counter sleep aids: caution (diphenhydramine, doxylamine)
  • Over-the-counter decongestants: monitor (pseudoephedrine, phenylephrine)
  • Blood-pressure-lowering supplements: caution (beetroot or dietary nitrate, aged garlic extract, magnesium, high-dose omega-3 fatty acids)
  • Glucose-lowering supplements: caution (berberine, chromium picolinate, alpha-lipoic acid, cinnamon extract)
  • Other movement and mind-body interventions: monitor (tai chi, yoga, vestibular rehabilitation)
  • Meditation and breathwork programs: caution (Wim Hof, holotropic breathing)

Risk & Side Effects

  • High: Transient musculoskeletal soreness and joint pain
  • Medium: Dizziness, palpitations and chest tightness during practice
  • Low: Adverse psychological reactions; delayed or forgone conventional treatment
  • Speculative: Cardiovascular strain from prolonged static postures

Monitoring

Marker Target Why
Resting blood pressure 110–120 / 70–78 mmHg The best-evidenced outcome of this practice
Resting heart rate 50–65 beats per minute Tracks the parasympathetic shift the practice is proposed to produce
Heart rate variability No established universal target; track change from the individual's own 14-day baseline Direct readout of vagus-nerve activity, the proposed mechanism
Glycated hemoglobin 4.8–5.4% Captures the glycemic effect seen in diabetes trials
Fasting glucose 75–86 mg/dL More responsive than glycated hemoglobin over a 12-week block
Triglycerides Below 80 mg/dL The lipid fraction that moved in metabolic syndrome trials
High-sensitivity C-reactive protein Below 0.7 mg/L Tests whether any anti-inflammatory effect occurs in the individual
Timed Up and Go Below 10 seconds; above 12 seconds indicates elevated fall risk The balance and mobility outcome with the strongest trial support
Lumbar spine bone mineral density T-score above −1.0 The only high-certainty skeletal benefit identified
Pittsburgh Sleep Quality Index Total score below 5 Detects the sleep effect, which is among the earliest to appear

Cadence: Blood pressure weekly at home for the first eight weeks, then monthly. Glycated hemoglobin, lipids and inflammation at 12 weeks, then every six months. The balance measure at 12 weeks and every six months. Bone density only at 12 to 24 months.

Qualitative Assessment

  • Sleep onset latency and number of night wakings, recorded weekly
  • Perceived steadiness on stairs, uneven ground and when turning quickly
  • Morning stiffness and joint comfort in the knees, hips and lower back
  • Daytime energy and the presence or absence of an afternoon slump
  • Reactivity to everyday stressors, and how quickly composure returns afterwards
  • Ease of the practice itself — whether the 40-minute sequence has stopped feeling effortful